Alternative splicing regulation of telomerase: a new paradigm?
暂无分享,去创建一个
J. Shay | W. Wright | Mandy S. Wong | M. Wong
[1] T. Cech,et al. Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT , 2014, Nucleic acids research.
[2] I. Topisirovic,et al. Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase. , 2014, Biochimie.
[3] J. Shay,et al. Regulation of human telomerase splicing by RNA:RNA pairing , 2014, Nature Communications.
[4] O. Podhajcer,et al. The low‐abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer , 2014, International journal of cancer.
[5] Jean-François Lucier,et al. Tumor microenvironment–associated modifications of alternative splicing , 2014, RNA.
[6] E. Blackburn,et al. Molecular and Cellular Pathobiology The Major Reverse Transcriptase – Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis , 2013 .
[7] J. Shay,et al. Regulation of telomerase alternative splicing: a target for chemotherapy. , 2013, Cell reports.
[8] A. Krainer,et al. Pick one, but be quick: 5' splice sites and the problems of too many choices. , 2013, Genes & development.
[9] C. Milcarek,et al. Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms , 2013, Cancer Immunology, Immunotherapy.
[10] J. Valcárcel,et al. The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.
[11] R. Hrdličková,et al. Alternatively Spliced Telomerase Reverse Transcriptase Variants Lacking Telomerase Activity Stimulate Cell Proliferation , 2012, Molecular and Cellular Biology.
[12] R. Padgett. New connections between splicing and human disease. , 2012, Trends in genetics : TIG.
[13] Dmitri D. Pervouchine,et al. conserved long-range RNA structures Evidence for widespread association of mammalian splicing and Material Supplemental , 2011 .
[14] M. Hagiwara,et al. Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor , 2011, The Journal of cell biology.
[15] M. Pagel,et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.
[16] D. Auboeuf,et al. Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation , 2011, The Journal of cell biology.
[17] B. Graveley. The developmental transcriptome of Drosophila melanogaster , 2010, Nature.
[18] F. Döring,et al. Specific regulation of low-abundance transcript variants encoding human Acyl-CoA binding protein (ACBP) isoforms , 2010, Journal of cellular and molecular medicine.
[19] Matthieu Legendre,et al. Variable tandem repeats accelerate evolution of coding and regulatory sequences. , 2010, Annual review of genetics.
[20] P. Rudland,et al. Microarray Analysis of Suppression Subtracted Hybridisation Libraries Identifies Genes Associated with Breast Cancer Progression , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[21] T. Nilsen,et al. Expansion of the eukaryotic proteome by alternative splicing , 2010, Nature.
[22] J. Pritchard,et al. Characterizing natural variation using next-generation sequencing technologies. , 2009, Trends in genetics : TIG.
[23] Timothy D. Veenstra,et al. Telomerase modulates Wnt signalling by association with target gene chromatin , 2009, Nature.
[24] Gene W. Yeo,et al. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells , 2009, Nature Structural &Molecular Biology.
[25] Sandrine Dudoit,et al. Novel Low Abundance and Transient RNAs in Yeast Revealed by Tiling Microarrays and Ultra High–Throughput Sequencing Are Not Conserved Across Closely Related Yeast Species , 2008, PLoS genetics.
[26] Wilhelm Palm,et al. How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.
[27] J. Eshleman,et al. Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms. , 2008, Thyroid : official journal of the American Thyroid Association.
[28] Kai-Wei Chang,et al. RNA-binding proteins in human genetic disease. , 2008, Trends in genetics : TIG.
[29] William Ritchie,et al. Entropy Measures Quantify Global Splicing Disorders in Cancer , 2008, PLoS Comput. Biol..
[30] Gil Ast,et al. Alternative splicing and disease , 2008, RNA biology.
[31] K. Hui,et al. Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis , 2007, Oncogene.
[32] Gil Ast,et al. Insights into the connection between cancer and alternative splicing. , 2008, Trends in genetics : TIG.
[33] Guey-Shin Wang,et al. Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.
[34] N. Bache,et al. Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.
[35] Michael Q. Zhang,et al. Pan‐genome isolation of low abundance transcripts using SAGE tag , 2006, FEBS letters.
[36] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[37] G. Gaudernack,et al. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues , 2006, BMC Molecular Biology.
[38] B. Blencowe. Alternative Splicing: New Insights from Global Analyses , 2006, Cell.
[39] A. Kornblihtt,et al. The connection between splicing and cancer , 2006, Journal of Cell Science.
[40] J. Venables. Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[41] B. Graveley. Coordinated control of splicing and translation , 2005, Nature Structural &Molecular Biology.
[42] Brenton R Graveley,et al. Mutually Exclusive Splicing of the Insect Dscam Pre-mRNA Directed by Competing Intronic RNA Secondary Structures , 2005, Cell.
[43] M. Moore. From Birth to Death: The Complex Lives of Eukaryotic mRNAs , 2005, Science.
[44] Jian Wang,et al. Detecting novel low-abundant transcripts in Drosophila. , 2005, RNA.
[45] L. Latonen,et al. hTERT antagonizes p53-induced apoptosis independently of telomerase activity , 2005, Oncogene.
[46] R. Moyzis,et al. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma , 1999, Breast Cancer Research and Treatment.
[47] Melissa S Jurica,et al. Pre-mRNA splicing: awash in a sea of proteins. , 2003, Molecular cell.
[48] Christopher J. Lee,et al. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.
[49] M. Fukuda. Roles of mucin-type O-glycans in cell adhesion. , 2002, Biochimica et biophysica acta.
[50] N. Zaffaroni,et al. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity , 2002, The Journal of pathology.
[51] Jun-Ping Liu,et al. TERT regulates cell survival independent of telomerase enzymatic activity , 2002, Oncogene.
[52] J. Klein,et al. Bioessays news and reviews in molecular, cellular and developmental biology , 2002 .
[53] J. Shay,et al. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. , 2001, Nucleic acids research.
[54] M. Garcia-Blanco,et al. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. , 2001, Gene.
[55] J. Griffith,et al. T‐loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang , 2001, The EMBO journal.
[56] E. Blackburn. Switching and Signaling at the Telomere , 2001, Cell.
[57] L. Giudice,et al. Tissue‐specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development , 2001, International journal of cancer.
[58] J. Shay,et al. Telomerase inhibitors. , 2001, Trends in biotechnology.
[59] Piero Carninci,et al. Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes. , 2000, Genome research.
[60] A. Kilian,et al. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. , 2000, Neoplasia.
[61] J. Shay,et al. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. , 2000, Neoplasia.
[62] R. Insel,et al. Up‐regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit , 1999, European journal of immunology.
[63] D. Bowtell,et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.
[64] R. Reddel. Telomerase and cancer. , 1997, Japanese journal of cancer research : Gann.
[65] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[66] Aaron P. Campbell,et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Shay,et al. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. , 1996, The EMBO journal.
[68] J. Shay,et al. The reactivation of telomerase activity in cancer progression. , 1996, Trends in genetics : TIG.
[69] J. Shay,et al. Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.
[70] H. Klamut,et al. The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced , 1995, Nature Genetics.
[71] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[72] M. Ligtenberg,et al. Cell membrane-associated mucins and their adhesion-modulating property. , 1992, Trends in biochemical sciences.
[73] C B Harley,et al. Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.
[74] C B Harley,et al. Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.
[75] C. Greider. Telomeres, telomerase and senescence , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.
[76] Y. Osheim,et al. Splice site selection, rate of splicing, and alternative splicing on nascent transcripts. , 1988, Genes & development.
[77] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[78] A M Olovnikov,et al. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.